Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 1
1986 3
1987 3
1988 6
1989 5
1990 4
1991 1
1992 1
1993 1
1994 5
1995 7
1996 13
1997 10
1998 6
1999 4
2000 5
2001 8
2002 10
2003 13
2004 10
2005 9
2006 13
2007 9
2008 16
2009 12
2010 6
2011 8
2012 14
2013 17
2014 11
2015 16
2016 13
2017 13
2018 16
2019 9
2020 11
2021 11
2022 16
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

325 results

Results by year

Filters applied: . Clear all
Page 1
The functional role of Nudt2 in human triple negative breast cancer.
Abu-Rahmah R, Nechushtan H, Hidmi S, Meirovitz A, Razin E, Peretz T. Abu-Rahmah R, et al. Among authors: peretz t. Front Oncol. 2024 Apr 23;14:1364663. doi: 10.3389/fonc.2024.1364663. eCollection 2024. Front Oncol. 2024. PMID: 38715773 Free PMC article.
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.
Martín M, Lim E, Chavez-MacGregor M, Bardia A, Wu J, Zhang Q, Nowecki Z, Cruz FM, Safin R, Kim SB, Schem C, Montero AJ, Khan S, Bandyopadhyay R, Moore HM, Shivhare M, Patre M, Martinalbo J, Roncoroni L, Pérez-Moreno PD, Sohn J; acelERA Breast Cancer Study Investigators. Martín M, et al. J Clin Oncol. 2024 Mar 27:JCO2301500. doi: 10.1200/JCO.23.01500. Online ahead of print. J Clin Oncol. 2024. PMID: 38537155
Short report: Plasma based biomarkers detect radiation induced brain injury in cancer patients treated for brain metastasis: A pilot study.
Makranz C, Lubotzky A, Zemmour H, Shemer R, Glaser B, Cohen J, Maoz M, Sapir E, Wygoda M, Peretz T, Weizman N, Feldman J, Abrams RA, Lossos A, Dor Y, Zick A. Makranz C, et al. Among authors: peretz t. PLoS One. 2023 Nov 28;18(11):e0285646. doi: 10.1371/journal.pone.0285646. eCollection 2023. PLoS One. 2023. PMID: 38015964 Free PMC article.
Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cells.
Granit Mizrahi A, Gugenheim A, Hamad H, Hamed R, Tetro N, Maimon O, Khutsurauli S, Nechushtan H, Nisman B, Duran D, Samman W, Birimberg-Schwartz L, Grunewald M, Eyal S, Peretz T. Granit Mizrahi A, et al. Among authors: peretz t. Front Cell Dev Biol. 2023 Oct 26;11:1217149. doi: 10.3389/fcell.2023.1217149. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37954205 Free PMC article.
In Response.
Nisman B, Oleinikov K, Nechushtan H, Maimon O, Atlan K, Peled N, Gross D, Peretz T, Meirovitz A, Grozinsky-Glasberg S. Nisman B, et al. Among authors: peretz t. J Thorac Oncol. 2023 Nov;18(11):e139-e141. doi: 10.1016/j.jtho.2023.08.032. J Thorac Oncol. 2023. PMID: 37879775 No abstract available.
A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapy.
Golan S, Bar V, Salpeter SJ, Neev G, Creiderman G, Kedar D, Aharon S, Turovsky L, Zundelevich A, Shahar H, Shapira H, Mallel G, Stossel E, Gavert N, Straussman R, Dotan Z, Berger R, Stossel C, Golan T, Halperin S, Leibovici D, Breuer S, Rottenberg Y, Applebaum L, Hubert A, Nechushtan H, Peretz T, Zick A, Chertin B, Koulikov D, Sonnenblick A, Rosenbaum E. Golan S, et al. Among authors: peretz t. Front Med (Lausanne). 2023 Sep 28;10:1221484. doi: 10.3389/fmed.2023.1221484. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37840996 Free PMC article.
Rapid Classification of Sarcomas Using Methylation Fingerprint: A Pilot Study.
Iluz A, Maoz M, Lavi N, Charbit H, Or O, Olshinka N, Demma JA, Adileh M, Wygoda M, Blumenfeld P, Gliner-Ron M, Azraq Y, Moss J, Peretz T, Eden A, Zick A, Lavon I. Iluz A, et al. Among authors: peretz t. Cancers (Basel). 2023 Aug 18;15(16):4168. doi: 10.3390/cancers15164168. Cancers (Basel). 2023. PMID: 37627196 Free PMC article.
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez Moreno HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Morales Murillo S, Okera M, Park YH, Sohn J, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin EC, Grinsted L, Schiavon G, Foxley A, Rugo HS; CAPItello-291 Study Group. Turner NC, et al. N Engl J Med. 2023 Jun 1;388(22):2058-2070. doi: 10.1056/NEJMoa2214131. N Engl J Med. 2023. PMID: 37256976 Clinical Trial.
325 results